CMS will conduct a drug acquisition cost survey in early 2026 to collect data from hospitals under the Medicare OPPS, informing 2027 outpatient payment policies.

CMS announces 2026 updates for OPPS and ASC payment systems, including expanded site neutral payments, skin substitute product unbundling, IPO list phase-out, and new hospital price transparency requirements.

CMS initiates survey collecting hospital outpatient drug acquisition costs to align Medicare payments with actual costs under the 2026 OPPS update, following a federal Executive Order to reduce prescription drug expenses.